ask="0.9550"
ask_size="200"
average_daily_volume="363443"
bid="0.9505"
bid_size="1300"
book_value="0.2980"
change="+0.0047"
change_from_200_day_moving_average="-0.4279"
change_from_50_day_moving_average="-0.0203"
change_from_52_week_high="-1.6901"
change_From_52_week_low="0.0999"
change_in_percent="+0.4920%"
close="0.9599"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.5380"
ebitda="-24.87M"
eps_estimate_current_year="-0.4800"
eps_estimate_next_quarter="-0.1500"
eps_estimate_next_year="-0.3500"
ex_dividend_date="N/A"
float_shares="50898000"
high="0.9600"
high_52_weeks="2.6500"
last_trade_date="1/6/2017"
last_trade_price="0.9599"
last_trade_size="200"
last_trade_time="4:02pm"
low="0.9500"
low_52_weeks="0.8600"
market_capitalization="53.51M"
moving_average_200_day="1.3878"
moving_average_50_day="0.9802"
name="Actinium Pharmaceuticals
Inc. "
notes="N/A"
one_year_target_price="7.3300"
open="0.9600"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-30.8345%"
percent_change_from_50_day_moving_average="-2.0692%"
percent_change_from_52_week_high="-63.7774%"
percent_change_from_52_week_low="+11.6163%"
previous_close="0.9552"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.2054"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="55747000"
short_ratio="5.3300"
stock_exchange="ASE"
symbol="ATNM"
volume="110139"
weeks_range_52="0.8600 - 2.6500"
